Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2023-02-14 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE Limited and National Stock Exchange of India) regarding the publication of newspaper advertisements about the company's unaudited financial results for the quarter and nine months ended December 31, 2022. It references Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, which mandates disclosure of financial results. The document is primarily an announcement that copies of the newspaper advertisements of the unaudited financial results have been published and enclosed for information and records. It does not contain the actual financial statements or detailed financial analysis but rather serves as a notification of the publication of the results. The document length is about 15,000 characters, but the content is focused on the announcement of the advertisement publication, not the financial report itself. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the publication of financial results advertisements, not the financial results report itself.
2023-02-14 English
Updates
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying a change in the name and scope of a board committee, specifically the Risk Management Committee being renamed to Risk & Sustainability Committee to include ESG matters. It is an announcement related to board/management information rather than a financial report, audit, or regulatory filing. The content focuses on governance and board committee structure changes, which fits the Board/Management Information category (MANG). The document length is short and does not contain financial data or detailed report content, so it is not an Annual Report or similar. Therefore, the classification is MANG with high confidence.
2023-02-13 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2022. It includes financial statements, notes, and auditor's review reports pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presence of comprehensive financial data, management approval, and auditor review indicates this is an Interim / Quarterly Report rather than a mere announcement or certification. The document length (15,000 characters) and content confirm it is a substantive financial report for a period shorter than a full fiscal year, consistent with the definition of an Interim / Quarterly Report (IR).
2023-02-13 English
Financial Result Updates
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement from Neuland Laboratories Limited regarding the approval of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2022. It includes the financial statements themselves, notes, and auditor's review reports pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presence of actual financial data, comprehensive financial results, and auditor's review confirms this is an Interim / Quarterly Report. The document is lengthy (15,000 characters) and contains substantive financial data, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-02-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Earnings Release Classification · 95% confidence The document is a letter addressed to stock exchanges announcing the schedule for the Q3 FY 2023 earnings call of Neuland Laboratories Limited. It references the upcoming announcement of quarterly financial results and provides details for the earnings call event. The document does not contain actual financial statements or detailed financial analysis but serves as a notice for the earnings release and the related conference call. The document length is short (2747 characters) and primarily serves as an announcement rather than the earnings release itself. Therefore, it fits best under the category of Earnings Release (ER) announcement or Earnings Call Notice. Given the content, the most appropriate classification is Earnings Release (ER) as it announces the upcoming release of quarterly results and the earnings call schedule. Q3 2023
2023-02-02 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates by a shareholder and the request for issuance of a 'Letter of Confirmation' in lieu of physical share certificates. It references Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is an official notification to exchanges about a shareholder's lost certificates, not a financial report, management change, or voting result. It is a regulatory announcement related to shareholding but does not indicate a change in major shareholding levels or insider transactions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.